These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8711255

  • 1. [Alpha interferon in the therapy of polycythemia vera].
    Castello G, Lerza R, Cavallini D, Ballarino P, Cerruti A, Bogliolo G, Pannacciulli I.
    Recenti Prog Med; 1996 Jan; 87(1):7-11. PubMed ID: 8711255
    [Abstract] [Full Text] [Related]

  • 2. [Interferon alpha in the treatment of polycythemia vera in a 13-year-old girl].
    Ołpiński M, Jakieła T, Korczowski R.
    Pediatr Pol; 1996 Aug; 71(8):705-7. PubMed ID: 8927476
    [Abstract] [Full Text] [Related]

  • 3. Alpha-interferon in polycythemia vera and essential thrombocythemia.
    Turri D, Mitra ME, Di Trapani R, Lipari MG, Perricone R, Cajozzo A.
    Haematologica; 1991 Aug; 76(1):75-7. PubMed ID: 2055565
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of the treatment of polycythemia vera with recombinant interferon-alpha.
    Silver RT.
    Cancer; 2006 Aug 01; 107(3):451-8. PubMed ID: 16804923
    [Abstract] [Full Text] [Related]

  • 5. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M, Fujimura M, Kawamura K, Suzuki S, Hamano M, Nishikawa Y, Nagayama T.
    Int J Urol; 2005 May 01; 12(5):442-8. PubMed ID: 15948742
    [Abstract] [Full Text] [Related]

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 May 01; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
    Nemets A, Isakov I, Huerta M, Barshai Y, Oren S, Lugassy G.
    Isr Med Assoc J; 2006 Dec 01; 8(12):845-7. PubMed ID: 17214101
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of human leucocyte interferon-alpha treatment in patients younger than 60 years of age with polycythaemia vera.
    Stasi R, Brunetti M, Bussa S, Venditti A, Del Poeta G, Conforti M, Scimò MT, Cudillo L, Adorno G, Cecconi M, Amadori S, Pagano A.
    J Intern Med; 1997 Aug 01; 242(2):143-7. PubMed ID: 9279291
    [Abstract] [Full Text] [Related]

  • 9. [Polycytemia vera in an 11-year old girl].
    Nagy K, Hunyadi K, Fehér I, Tamáska J, Zsíros J, Simkó R, Vámosi I.
    Orv Hetil; 1996 Jan 07; 137(1):27-30. PubMed ID: 8721860
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of interferon alpha-2a in the treatment of polycythemia vera.
    Foa P, Massaro P, Ribera S, Iurlo A, Mezzanotte C, Giandalia D, Maiolo AT.
    Am J Hematol; 1995 Jan 07; 48(1):55-7. PubMed ID: 7832194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Interferon therapy in essential thrombocythemia].
    Seewann HL.
    Wien Med Wochenschr; 1993 Jan 07; 143(16-17):420-4. PubMed ID: 8273365
    [Abstract] [Full Text] [Related]

  • 14. Polycythemia vera in a patient with the human immunodeficiency virus: a case report.
    Sassaki MG, Souza CA, Siciliano RF, Leite AG, Padilha SL.
    Braz J Infect Dis; 2000 Aug 07; 4(4):204-7. PubMed ID: 11184768
    [Abstract] [Full Text] [Related]

  • 15. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors.
    Lin SM, Lin CJ, Hsu CW, Tai DI, Sheen IS, Lin DY, Liaw YF.
    Cancer; 2004 Jan 15; 100(2):376-82. PubMed ID: 14716774
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
    McHutchison JG, Shiffman ML, Cheung RC, Gordon SC, Wright TL, Pottage JC, McNair L, Ette E, Moseley S, Alam J.
    Antivir Ther; 2005 Jan 15; 10(5):635-43. PubMed ID: 16152757
    [Abstract] [Full Text] [Related]

  • 17. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy.
    Van Thiel DH, Friedlander L, Molloy PJ, Kania RJ, Fagiuoli S, Wright HI, Gasbarrini A, Caraceni P.
    Hepatogastroenterology; 1996 Jan 15; 43(12):1557-61. PubMed ID: 8975965
    [Abstract] [Full Text] [Related]

  • 18. Recombinant interferon alpha-2b in the treatment of polycythemia vera.
    Cimino R, Rametta V, Matera C, Mele G, Mettivier V, Ferrara F.
    Am J Hematol; 1993 Nov 15; 44(3):155-7. PubMed ID: 8213763
    [Abstract] [Full Text] [Related]

  • 19. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO.
    Liver Transpl; 2001 Oct 15; 7(10):863-9. PubMed ID: 11679984
    [Abstract] [Full Text] [Related]

  • 20. Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study.
    Merx K, Fabarius A, Erben P, Griesshammer M, Reiter A, Hofmann WK, Hehlmann R, Hochhaus A, Lengfelder E.
    Ann Hematol; 2013 Jul 15; 92(7):907-15. PubMed ID: 23525684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.